Bank Of Montreal Alkermes Plc. Call Options Transaction History

Bank Of Montreal

  • $214 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 02, 2023
SELL
$28.34 - $33.63 $3.06 Million - $3.63 Million
-107,800 Reduced 68.31%
50,000 $1.57 Million
Q1 2023

Jun 13, 2024
BUY
$25.31 - $29.02 $2.53 Million - $2.9 Million
99,900 New
99,900 $2.82 Million
Q4 2022

Feb 01, 2023
BUY
$21.94 - $26.24 $1.49 Million - $1.78 Million
67,800 Added 75.33%
157,800 $4.12 Million
Q3 2022

Nov 10, 2022
BUY
$22.0 - $31.87 $1.98 Million - $2.87 Million
90,000 New
90,000 $2.15 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email